To add to my previous post.
I strongly believe we don't want to go into a design freeze as the key cash flow catalyst. Because 1) the cash may still not come immediately and 2) they know the company will give them a favourable deal due to pressure from shareholders which will get the monkey off their back but limit the upsides we deserve aka they will exploit us.
If we go into negotiations with MB and the other EVs think of the power Fabian would have knowing we are not
desperate for cash or have the need for dilution.
Think of the upfront cash deal or equity buy in that we could negotiate in the that position it would be pie in the sky out come for us long suffering long termers.
Life sciences in the next 6-12months is of massive importance.
All imo
Add to My Watchlist
What is My Watchlist?
